]>
Cambiar país/idioma: България (Български език) Cambiar país/idioma: Česká republika (Čeština) Cambiar país/idioma: Deutschland (Deutsch) Cambiar país/idioma: Ελλάδα (Ελληνικά) Cambiar país/idioma: United Kingdom (English) Cambiar país/idioma: United States (English) Cambiar país/idioma: España (Español) Cambiar país/idioma: Suomi (Suomi) Cambiar país/idioma: France (Français) Cambiar país/idioma: Magyarország (Magyar) Cambiar país/idioma: Italia (Italiano) Cambiar país/idioma: Nederland (Nederlands) Cambiar país/idioma: Polska (język polski) Cambiar país/idioma: Portugal (Português) Cambiar país/idioma: România (limba româna) Cambiar país/idioma: Россия (Русский язык) Cambiar país/idioma: Sverige (Svenska)

Teléfono:

+34 (0)93 308 4181

El homepage > Pharmaceutical reference standards & impurities > WHO International Standards for Antibiotics > Rifamycin SV

WHO International Standards for Antibiotics

Rifamycin SV

EPISA_66_231

100mg Unidad

All Pharmacopoeial standards should be used in accordance with the relevant monographs. Any other use is at the risk of the user.

Por favor login ó registrese para posibilitar la compra



printVista de impresión
Identificarse
No registrado ¿Olvidó la contraseña?
Descargar nuestros catalogos

Novedades y Eventos

LGC Standards offers world’s first certified reference nanomaterial
The world's first certified nanoparticle reference material set to improve comparability of measurements worldwide leer mas >>

Industry news

Outbreak of kidney failure in Wyoming linked to Spice | The Raw Story
(Reuters) Three young people have been hospitalized with kidney failure and a dozen others sickened in Casper, Wyoming, in an outbreak linked to a ... leer mas >>